No Data
No Data
No Data
No Data
No Data
Sanyou Healthcare (688085.SH): Net loss of 2,095,800 yuan in the first quarter
Gelonghui, April 25 | Sanyou Medical (688085.SH) released its report for the first quarter of 2024. During the reporting period, it achieved operating income of 86.4293 million yuan, a year-on-year decrease of 46.26%; net profit attributable to shareholders of listed companies - 2,0955,800 yuan; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss - RMB 2,9516 million; and basic earnings per share - 0.01 yuan.
Gelonghui FinanceApr 25 04:29 ET
Calculating The Intrinsic Value Of Shanghai Sanyou Medical Co., Ltd (SHSE:688085)
Key Insights The projected fair value for Shanghai Sanyou Medical is CN¥16.87 based on 2 Stage Free Cash Flow to Equity Current share price of CN¥17.97 suggests Shanghai Sanyou Medical is potentiall
Simply Wall StApr 15 23:26 ET
Retail Investors Invested in Shanghai Sanyou Medical Co., Ltd (SHSE:688085) Copped the Brunt of Last Week's CN¥373m Market Cap Decline
Key Insights The considerable ownership by retail investors in Shanghai Sanyou Medical indicates that they collectively have a greater say in management and business strategy 51% of the business is
Simply Wall StMar 25 21:52 ET
Sanyou Medical (688085.SH): The actual controller increased its total holdings by 25.20.28 million yuan and completed the increase in shares
Gelonghui March 20 | Sanyou Medical (688085.SH) announced that as of March 20, 2024, the company's actual controllers, Mr. Xu Nong, Mr. Michael MingyanLiu (Liu Mingyan), and Mr. DavidFan (Fan Xianglong), increased their holdings by a total of 25.202,800 yuan, increasing their holdings by 1,597,464 shares, accounting for 0.64%. Among them, Mr. Xu Nong increased his holdings of the company's shares by 1,043,387 shares through centralized bidding through the Shanghai Stock Exchange trading system, accounting for 0.42% of the company's total share capital, with an increase of 1,600
Gelonghui FinanceMar 20 06:24 ET
Sanyou Medical (688085.SH): The overall number of terminal surgeries has further increased, and the number of products shipped has increased markedly
Gelonghui, March 19 | Sanyou Medical (688085.SH) said on the interactive platform that in 2023, due to the implementation of the national procurement of high-value spinal consumables, the company's spinal product terminal admission price dropped sharply, leading to a decline in the company's operating income and net profit. However, the company's sales team actively implemented the company's sales plan and used collection to enter the company's sales gap area to increase terminal hospital coverage. The company's overall terminal operation volume further increased, and the number of products shipped increased markedly. In the future, the company will continue to strengthen therapeutic innovation and sales expansion, continue to deepen the decline in sales channels, and actively expand the international market
Gelonghui FinanceMar 19 05:43 ET
There Are Reasons To Feel Uneasy About Shanghai Sanyou Medical's (SHSE:688085) Returns On Capital
What are the early trends we should look for to identify a stock that could multiply in value over the long term? One common approach is to try and find a company with returns on capital employed (RO
Simply Wall StFeb 26 21:35 ET
No Data
No Data